Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial
Bengt I. Eriksson(Sahlgrenska University Hospital), Ola E. Dahl(Thrombosis Research Institute), Nadia Rosencher(Hôpital Cochin), Andreas Kurth(Orthopaedic University Hospital Friedrichsheim), C. Niek van Dijk(Academic Medical Center), Simon P. Frostick(Royal Liverpool University Hospital), Martin H. Prins(Maastricht University), Rohan Hettiarachchi(Boehringer Ingelheim (Netherlands)), Stefan Hantel(Boehringer Ingelheim (Germany)), Janet Schnee(Boehringer Ingelheim (United States)), Harry R. Büller(Academic Medical Center)
Cited by 1,115
Abstract
Related Papers
No related papers found
Powered by citation graph analysis